Polish HealthTech Startup MY OVU Wins CTA Pitch Competition, Secures Spot at CES 2027

Warsaw Summit Propels Polish Innovation to Las Vegas

The Consumer Technology Association (CTA) has named Polish health technology startup MY OVU the winner of its high-stakes pitch competition held during the CTA CEO Summit in Warsaw. This victory grants the company complimentary exhibition space at Eureka Park during CES 2027 in Las Vegas.

The competition served as a rigorous vetting process, featuring five of Poland's most promising startups. A panel of veteran venture capital investors evaluated the entries based on commercial scalability, strategic vision, and technological disruption.

By securing this win, MY OVU gains direct access to an international ecosystem of venture capitalists, corporate executives, and global media, marking a significant leap from a regional innovator to a global contender.

Redefining Reproductive Health Through Smart Data

MY OVU distinguishes itself through the development of an intelligent ovulation thermometer. Unlike traditional tracking tools, the device integrates precision monitoring with smart analytics to provide actionable health insights.

The technology is designed to support women across various reproductive stages, including:

Conception: Precision tracking for those attempting to conceive.
Fertility Monitoring: Comprehensive cycle analysis for general health.
Perimenopause: Navigating the physiological shifts associated with the transition to menopause.

The judging panel highlighted the startup's ability to convert raw temperature data into meaningful health narratives, moving beyond simple recording to provide a deeper understanding of biological patterns.

Strategic Bridge Between Europe and Global Markets

The CTA is actively expanding its footprint in Europe to bridge the gap between emerging regional talent and the North American market. Through the "Road to CES" initiatives, the association provides a structured pipeline for European startups to achieve international visibility.

Kinsey Fabrizio, President and CEO of the CTA, noted that Poland’s entrepreneurial community is increasingly capable of competing on a global scale. This collaboration is further supported by the Polish Agency for Enterprise Development, which helps localize and promote Polish innovation at the Las Vegas event.

To maintain this momentum, the CTA will host several precursor events leading up to 2027, including:

CES Tech Trends with FDDay
CES Unveiled Amsterdam
CES Unveiled Milan

The Significance of Eureka Park for Scaling Startups

For a startup, a presence in Eureka Park is more than just a booth; it is a strategic launchpad. This dedicated section of CES is renowned for introducing "the next big thing" to the world's largest concentration of technology buyers and strategic partners.

For MY OVU, the 2027 showcase represents a critical opportunity to:

Negotiate international distribution agreements.
Secure late-stage venture capital funding.
Establish cross-border research collaborations.
Validate their product-market fit on a global scale.

Investment Analysis and Regional Trends

The selection of MY OVU was determined by a panel of industry experts who brought diverse perspectives from the European investment landscape.

Judge	Firm/Organization	Focus Area
Zuzanna Kompowska	Inovo VC	Venture Capital
Kris Palucki	OTB Ventures	Venture Capital
Paulina Brym-Ciuba	StartupHub Poland	Startup Ecosystem Growth

This victory underscores a broader trend in Central and Eastern Europe, where government-backed initiatives and private VC funding are fueling a surge in "FemTech" and preventive healthcare solutions. The integration of AI and connected devices is transforming how personalized medical data is consumed, placing European startups at the forefront of the digital health revolution.

Key Takeaways

Global Recognition: MY OVU is the first winner of the Warsaw CTA CEO Summit pitch, heading to CES 2027.
Product Focus: The startup specializes in an intelligent ovulation thermometer for fertility and perimenopause tracking.
Strategic Value: Eureka Park at CES provides a high-visibility platform for securing international partnerships and funding.
Regional Growth: Poland is emerging as a critical hub for health-tech innovation within the European Union.

FAQ

What is MY OVU? MY OVU is a Polish health-tech startup that creates intelligent thermometers designed to track ovulation and reproductive health through data-driven insights.

What is Eureka Park? Eureka Park is a specialized exhibition area at CES (Consumer Electronics Show) in Las Vegas dedicated to showcasing early-stage startups and breakthrough innovations.

How did MY OVU win the competition? The company was selected by a panel of venture capitalists from Inovo VC, OTB Ventures, and StartupHub Poland based on its innovation, scalability, and market potential.